1. 2014 Company Profile

2. Bayer HealthCare Overview March 2014 AgendaBayer Overview Bayer HealthCare Pharmaceuticals Research & Development People and Responsibility Page 2

3. Our Mission: Science for a Better Life As an innovative healthcare company, we will Shape the future with innovations that will benefit the health and well-being of people and animals Lead the industry in our chosen therapeutic areas and direct research and development to therapeutic areas with a high unmet medical need Be respected for our high-performance culture and for attracting, retaining, and developing the best talents Be trusted by our customers Deliver on our promises to stakeholders Act in a socially responsible manner 3 Bayer HealthCare Overview March 2014

4. Business Areas Bayer HealthCare Overview March 2014Page 4

5. Bayer Business Areas Bayer HealthCare Bayer HealthCare is among the world’s foremost innovators in the field of pharmaceutical, medical and veterinary products. Bayer Crop Science Bayer Crop Science with its highly effective products, pioneering innovations and keen customer focus, holds global leadership positions in crop protection and non-agricultural pest control. Bayer Material Science Bayer Material Science is a renowned supplier of high-performance materials, such as polycarbonates and polyurethanes, and innovative system solutions for a wide range of everyday uses. Its products holding leading positions on many world markets. 5 Bayer HealthCare Overview March 2014

6. Innovation at Bayer Addressing Unmet Market Needs Bayer HealthCare Overview March 2014 Slide 6 In line with our mission “Bayer: Science For A Better Life” ChallengesOur ApproachInnovation Highlights Increasing quality of life, scarcer resources Bayer MaterialScience: New applications for high-tech materials and leading-edge processes technology Process advances: Using CO 2 as a component of synthesis Oxygen-depolarized cathode technology for the production of chlorine from salt Important launches: Xarelto™ Eylea™ Stivarga™ Growing need for food, feed and renewable resources Bayer CropScience: Solutions tailored to customer requirements, from seed to shelf Important launches: Alion™ Poncho™ / Votivo™ Xpro™ family Increased demand in growth markets, higher life expectancy, increasing requirements on healthcare industry Bayer HealthCare: Improving the health of people and animals; break-through innovation for diseases with a high medical need

7. Bayer HealthCare Divisions Bayer HealthCare Overview March 2014Page 7 Consumer Care Non-prescription drugs Rx Dermatology Vitamins Pharmaceuticals General Medicine Specialty Medicine Animal Health Food Animal Products Companion Animals Medical Care Diabetes Care Radiology & lnterventional

8. Bayer HealthCare Overview March 2014Page 8 Bayer HealthCare Pharmaceuticals

9. Bayer HealthCare Pharmaceuticals General Medicine Page 9 Bayer is among the world’s foremost innovators in the field of pharmaceuticals and medical products, and has the ambition to improve human health worldwide Our products bring benefits to people across a broad range of conditions Helping people with diabetes and cardiovascular risk management Anti-bacterial treatments to manage respiratory, urinary and surgical infections Therapies to bring benefit to people with testosterone deficiency and erectile dysfunction A broad Women’s Healthcare franchise including contraceptives, menopause management and gynecological therapies Products to prevent and treat venous and arterial thromboembolism Looking into the future, our clinical research focuses on the treatment of pulmonary, cardiovascular and gynecological diseases Bayer HealthCare Overview March 2014

10. Bayer HealthCare Pharmaceuticals Specialty Medicine Bayer HealthCare Overview March 2014Page 10 Bayer HealthCare is among the world’s leading companies in the fight against severe, chronic and life-threatening diseases Our experience lies in developing novel treatment options for patients leading to life-changing innovations: Effective therapy in Multiple Sclerosis Treatment to enable patients with Hemophilia A Therapies with significant survival benefit in liver cancer, colorectal cancer, and gastrointestinal tumors Product for the treatment of wet AMD Maximizing the value of a strong specialty pipeline by internal R&D capabilities and external partnerships to sustain long-term growth

11. Bayer HealthCare Pharmaceuticals Research Focus Bayer HealthCare Overview March 2014Page 11 Cardiology Pulmonary Hypertension / Heart Failure Thrombosis / Acute Coronary Syndrome Cardiorenal Syndrome (CRS) Oncology Cell Cycle / Survival Signaling Immunotherapy / Antibody- Drug Conjugates Tumor Metabolism / Hypoxia Chromatin Modulation / OncoGenomics Hematology Anemia and other blood diseases LCM long acting factor VIII Gynecological Therapy Endometriosis Uterine Fibroids Common Mechanism Research & Other Areas Leveraging the full potential of development compounds Ophthalmology Inflammation LCM Fertility Control / Menopause-Management Magnetic Resonance and Computed Tomography Contrast Media Research

12. Bayer HealthCare Overview March 2014Page 12 People and Responsibility

13. Sustainability Is an Integral Part of the Corporate Strategy Bayer HealthCare Overview March 2014 Slide 13 For us, sustainability means striking a balance between economic growth and ecological and social responsibility. The Bayer Group’s sustainable alignment is based on responsible business practices such as: High standards in occupational, process and plant safety Product stewardship across the entire value chain Responsible marketing Stringent compliance and anti-corruption directives Future-oriented human resources policy Strict supplier management

14. Corporate Social Responsibility Voluntary contributions to sustainable development Bayer HealthCare Overview March 2014 Slide 14 Commitment to progress in society – investments in gap-closing solutions Focus areas in science, education, social health and community development Co-creating contributions for the mutual benefit of society, community and industry Promote pioneering spirit on all levels in science & society Bridging company and non-profit – offering dialogue and idea exchange Making Science Make Sense offers programs for scientists, students, teachers and community volunteers Foundations – a strategic giving element since 1897 Bayer’s responsibility model is value oriented

15. Our Values Bayer HealthCare Overview March 2014Page 15 Leadership  Be passionate for people and performance  Show personal drive, inspire and motivate others  Be accountable for actions and results, successes and failures  Treat others fairly and with respect  Give clear, candid and timely feedback  Manage conflicts constructively  Create value for all our stakeholders Integrity  Be a role model  Comply with laws, regulations and good business practices  Trust others and build trustful relationships  Be honest and reliable  Listen attentively and communicate appropriately  Ensure sustainability: balance short-term results with long-term requirements  Care about people, safety and the environment Flexibility  Drive change actively  Be ready to adapt to future trends and needs  Challenge the status quo  Think and act with customers in mind  Seek out opportunities and take calculated risks  Be open-minded  Embrace lifelong learning Efficiency  Manage resources smartly  Focus on activities that create value  Do things simply and effectively  Deliver with appropriate costs, speed and quality  Speed up good decision-making  Be accountable for consistent execution  Collaborate for better solutions